ALMR NASDAQ
Alamar Biosciences, Inc.
1W: +2.0%
1M: -9.2%
3M: -1.8%
YTD: +10.9%
$24.71
+0.31 (+1.27%)
Weekly Expected Move ±8.5%
$21
$24
$26
$28
$30
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$8.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$231.7M
52W Range18.85-29.43
Volume189,972
Avg Volume294,241
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOYuling Luo
Employees222
SectorHealthcare
IndustryBiotechnology
IPO Date2026-04-17
Websitealamarbio.com
47071 Bayside Parkway
Fremont, CA 94538
US
Fremont, CA 94538
US
(510) 626-9888
About Alamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Latest News
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究
Alamar Biosciences 联合多所顶尖研究型大学推出全国性研究计划，推进神经退行性疾病血液生物标志物相关研究
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Alamar Biosciences 推出首款血液多重免疫檢測，用於檢測 eMTBR-Tau，它是阿茲海默症研究中最重要生物標記之一
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Qiming Corporate GP | C-Conversion | 6,881,410 | — | 2026-04-20 |
| Qiming Corporate GP | J-Other | 6,881,410 | — | 2026-04-20 |
| Qiming Corporate GP | J-Other | 1,922,329 | — | 2026-04-20 |
| Qiming Corporate GP | C-Conversion | 1,922,329 | — | 2026-04-20 |
| Qiming Corporate GP | J-Other | 1,605,645 | — | 2026-04-20 |